rs137852417
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PP3_StrongPP5_Very_Strong
The NM_000132.4(F8):c.1648C>T(p.Arg550Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000166 in 1,206,680 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000132.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F8 | ENST00000360256.9 | c.1648C>T | p.Arg550Cys | missense_variant | Exon 11 of 26 | 1 | NM_000132.4 | ENSP00000353393.4 | ||
F8 | ENST00000647125.1 | n.*1524C>T | non_coding_transcript_exon_variant | Exon 12 of 14 | ENSP00000496062.1 | |||||
F8 | ENST00000647125 | n.*1500C>T | 3_prime_UTR_variant | Exon 12 of 14 | ENSP00000496062.1 |
Frequencies
GnomAD3 genomes AF: 0.00000899 AC: 1AN: 111199Hom.: 0 Cov.: 22 AF XY: 0.0000299 AC XY: 1AN XY: 33401
GnomAD4 exome AF: 9.13e-7 AC: 1AN: 1095481Hom.: 0 Cov.: 30 AF XY: 0.00000277 AC XY: 1AN XY: 360893
GnomAD4 genome AF: 0.00000899 AC: 1AN: 111199Hom.: 0 Cov.: 22 AF XY: 0.0000299 AC XY: 1AN XY: 33401
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The F8 c.1648C>T; p.Arg550Cys variant (rs137852417, ClinVar Variation ID: 10223) is reported in the literature in multiple individuals affected with mild to moderate hemophilia A (see link to Factor VIII database and references therein, David 2006, Green 2008, Johnsen 2017, Lu 2018). This variant is absent from the Genome Aggregation Database (v2.1.1), indicating it is not a common polymorphism. Computational analyses predict that this variant is deleterious (REVEL: 0.749). Additionally, other amino acid substitutions at this codon (His, Pro, Leu, Gly) have been reported in individuals with hemophilia A and are considered pathogenic (Factor VIII database and references therein). Based on available information, this variant is considered to be pathogenic. References: Link to Factor VIII database: http://f8-db.eahad.org/ David D et al. The spectrum of mutations and molecular pathogenesis of hemophilia A in 181 Portuguese patients. Haematologica. 2006;91(6):840-843. PMID: 16769589. Green PM et al. Haemophilia A mutations in the UK: results of screening one-third of the population. Br J Haematol. 2008;143(1):115-128. PMID: 18691168. Johnsen JM et al. Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative. Blood Adv. 2017;1(13):824-834. PMID: 29296726. Lu Y et al. Spectrum and origin of mutations in sporadic cases of haemophilia A in China. Haemophilia. 2018;24(2):291-298. PMID: 29381227. -
Hereditary factor VIII deficiency disease Pathogenic:1
- -
Mild hemophilia A Pathogenic:1
The missense variant F8 c.1648C>T, p.Arg550Cys (p.R550C; legacy p.R531C) in exon 11 changes amino acid arginine at codon 550 to cysteine. The arginine at this residue is fairly well conserved among species. This amino acid change occurs at the interface of the A1 and A2 domains. Pathogenic variants in F8 are associated with X-linked hemophilia A characterized by mild to severe bleeding due to a quantitative or qualitative deficiency in factor VIII. This sequence variant has been previously reported in patients with mild to moderate hemophilia A, both with and without the development of inhibitors (PMID:1924291; PMID:8547094; PMID:16769589; PMID:17286776; PMID:20331753; PMID:23926300; PMID:29296726). Patients carrying this variant show discrepancy between 1-stage and 2-stage factor VIII activity assays, with a lower measurement recorded with 2-stage assay (PMID:17286776). This variant was observed in 6 males and 3 females within our laboratory cohort. All 6 males within our laboratory cohort had clot based factor VIII activity levels consistent with moderate or mild hemophilia A; 3 out of 6 males had VWD 2N ruled out by either a 2N binding assay or by negative next generation sequencing. The minor allele frequency of this variant in the general population is 0.000008993 (GnomAD v3). No functional data is available for this variant. In silico computational evidence (REVEL) predicts the variant to be damaging (>=0.644 ); however, computational evidence alone is not sufficient to classify a variant. Different variants causing a change at the same amino acid (c.1648C>G, p.R550G; c.1649G>A, p.R550H; c.1649G>T, p.R550L; c.1649G>C, p.R550P) have also been reported in patients with mild to severe hemophilia A (PMID:1924291; PMID:19473423; PMID:8547094; PMID:11157485; PMID:18179574; PMID:29296726). Functional studies of the alternate p.R550H variant using recombinant protein demonstrated a similar discrepant activity between 1-stage and 2-stage assays and showed an increased rate of A2 subunit dissociation correlating with inactivation of FVIIIa (PMID:11157485). In summary, the collective evidence supports F8 c.1648C>T, p.Arg550Cys as a pathogenic variant for mild to moderate hemophilia A. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at